The detailed information for PTAB case with proceeding number IPR2021-00439 filed by Nevakar, Inc. against Sydnexis, Inc. on Feb 3, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-00439
Filing Date
Feb 3, 2021
Petitioner
Nevakar, Inc.
Respondent
Sydnexis, Inc.
Status
Terminated-Settled
Respondent Application Number
14726139
Respondent Tech Center
1600
Respondent Patent Number
9421199
Termination Date
Apr 27, 2021

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Jul 2, 2021PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fees

Jun 16, 2021PAPERPETITIONER

Termination Decision Document

Apr 27, 2021PAPERBOARD

Joint Motion to Terminate

Apr 22, 2021PAPERPETITIONER

Joint Request to File Settlement Materials as Business Confidential Information and to Maintain Said Materials Separate from the Public File

Apr 22, 2021PAPERPETITIONER

Petitioner's Updated Exhibit List as of April 22, 2021

Apr 22, 2021PAPERPETITIONER

[CONFIDENTIAL] Sydnexis - Nevakar License Agreement

Apr 22, 2021EXHIBITPETITIONER

Patent Owner's Mandatory Notices

Feb 23, 2021PAPERPATENT OWNER

Power of Attorney

Feb 23, 2021PAPERPATENT OWNER

Notice of Accord Filing Date

Feb 10, 2021PAPERBOARD

US 9,421,199

Feb 3, 2021EXHIBITPETITIONER

Chia 2012

Feb 3, 2021EXHIBITPETITIONER

Kondritzer 1957

Feb 3, 2021EXHIBITPETITIONER

Siegel 1964

Feb 3, 2021EXHIBITPETITIONER

McBrien 2013

Feb 3, 2021EXHIBITPETITIONER

Chua 2006

Feb 3, 2021EXHIBITPETITIONER

Shih 2001

Feb 3, 2021EXHIBITPETITIONER

Wu 2007

Feb 3, 2021EXHIBITPETITIONER

Lee 2006

Feb 3, 2021EXHIBITPETITIONER

Fang 2010

Feb 3, 2021EXHIBITPETITIONER

Chia 2014

Feb 3, 2021EXHIBITPETITIONER

Tan 2012

Feb 3, 2021EXHIBITPETITIONER

Zvirblis 1956

Feb 3, 2021EXHIBITPETITIONER

Schier 2004

Feb 3, 2021EXHIBITPETITIONER

Kushner 1999

Feb 3, 2021EXHIBITPETITIONER

Blake 1975

Feb 3, 2021EXHIBITPETITIONER

Gant 2014

Feb 3, 2021EXHIBITPETITIONER

Foster 1985

Feb 3, 2021EXHIBITPETITIONER

Schowen 1978

Feb 3, 2021EXHIBITPETITIONER

Balamurugan 2009

Feb 3, 2021EXHIBITPETITIONER

Bayerl App No. 694

Feb 3, 2021EXHIBITPETITIONER

Krumbiegel 2011

Feb 3, 2021EXHIBITPETITIONER

Yarnell 2009

Feb 3, 2021EXHIBITPETITIONER

Timmins 2014

Feb 3, 2021EXHIBITPETITIONER

Anschel 1972

Feb 3, 2021EXHIBITPETITIONER

199 As Filed App (5-29-2015)

Feb 3, 2021EXHIBITPETITIONER

199 Non-Final Rejection (3-7-2016)

Feb 3, 2021EXHIBITPETITIONER

WoldeMussie

Feb 3, 2021EXHIBITPETITIONER

Wildosoet

Feb 3, 2021EXHIBITPETITIONER

Herekar

Feb 3, 2021EXHIBITPETITIONER

199 Remarks (4-5-2016)

Feb 3, 2021EXHIBITPETITIONER

199 Interview (4-13-2016)

Feb 3, 2021EXHIBITPETITIONER

199 NOA (6-13-2016)

Feb 3, 2021EXHIBITPETITIONER

447 Advisory Action 4-13-2017

Feb 3, 2021EXHIBITPETITIONER

502 App

Feb 3, 2021EXHIBITPETITIONER

433 App

Feb 3, 2021EXHIBITPETITIONER

Peichang (Translation & Original)

Feb 3, 2021EXHIBITPETITIONER

Remington 2013

Feb 3, 2021EXHIBITPETITIONER

Rajpal 2014

Feb 3, 2021EXHIBITPETITIONER

Kirchhoff 2004

Feb 3, 2021EXHIBITPETITIONER

Garcia-Valldecabres 2004

Feb 3, 2021EXHIBITPETITIONER

Patel 2010

Feb 3, 2021EXHIBITPETITIONER

Teva

Feb 3, 2021EXHIBITPETITIONER

Physiochemical Principals

Feb 3, 2021EXHIBITPETITIONER

O'Driscoll 2009

Feb 3, 2021EXHIBITPETITIONER

Furminger 1994

Feb 3, 2021EXHIBITPETITIONER

Berry

Feb 3, 2021EXHIBITPETITIONER

Bayerl App No. 596

Feb 3, 2021EXHIBITPETITIONER

Bender 1962

Feb 3, 2021EXHIBITPETITIONER

Winter 1968

Feb 3, 2021EXHIBITPETITIONER

Hasnson 2003

Feb 3, 2021EXHIBITPETITIONER

Li 2006 (Translation & Original)

Feb 3, 2021EXHIBITPETITIONER

Akorn Atropine PI

Feb 3, 2021EXHIBITPETITIONER

Wen 2008 (Translation & Original)

Feb 3, 2021EXHIBITPETITIONER

Brown 1965, Part 1 of 2

Feb 3, 2021EXHIBITPETITIONER

Brown 1965, Part 2 of 2

Feb 3, 2021EXHIBITPETITIONER

Kresege 1964

Feb 3, 2021EXHIBITPETITIONER

Driver 1999

Feb 3, 2021EXHIBITPETITIONER

FDA Guidance 2008

Feb 3, 2021EXHIBITPETITIONER

Chemistry Dictionary 2003

Feb 3, 2021EXHIBITPETITIONER

NaH2PO4 Data Sheet 2012

Feb 3, 2021EXHIBITPETITIONER

NaHPO4 Data Sheet 2009

Feb 3, 2021EXHIBITPETITIONER

Pfannkoch

Feb 3, 2021EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients 7th ed, Part 1 of 2

Feb 3, 2021EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients 7th ed, Part 2 of 2

Feb 3, 2021EXHIBITPETITIONER

Purandare

Feb 3, 2021EXHIBITPETITIONER

Gant 147 Application

Feb 3, 2021EXHIBITPETITIONER

Waterman 2002

Feb 3, 2021EXHIBITPETITIONER

Lin 2014

Feb 3, 2021EXHIBITPETITIONER

Susina 1962

Feb 3, 2021EXHIBITPETITIONER

Berton 2020

Feb 3, 2021EXHIBITPETITIONER

Remington 1995 Volume I

Feb 3, 2021EXHIBITPETITIONER

Akron Atropine PI Wayback Declaration with Ex. B

Feb 3, 2021EXHIBITPETITIONER

Badaro 2014

Feb 3, 2021EXHIBITPETITIONER

Karl 1993 (Translation & Original)

Feb 3, 2021EXHIBITPETITIONER

Remington 1995 Volume II, Part 1 of 3

Feb 3, 2021EXHIBITPETITIONER

Remington 1995 Volume II, Part 2 of 3

Feb 3, 2021EXHIBITPETITIONER

Remington 1995 Volume II, Part 3 of 3

Feb 3, 2021EXHIBITPETITIONER

IDS from App. No. 16/805,612

Feb 3, 2021EXHIBITPETITIONER

Barratt 2012

Feb 3, 2021EXHIBITPETITIONER

Shih 1999

Feb 3, 2021EXHIBITPETITIONER

Wu 2011

Feb 3, 2021EXHIBITPETITIONER

Glasoe 1960

Feb 3, 2021EXHIBITPETITIONER

Lallemand 2011

Feb 3, 2021EXHIBITPETITIONER

Minor 1972

Feb 3, 2021EXHIBITPETITIONER

Winter 1972

Feb 3, 2021EXHIBITPETITIONER

Jencks 1961

Feb 3, 2021EXHIBITPETITIONER

Donnelly 2008

Feb 3, 2021EXHIBITPETITIONER

Jencks 1993

Feb 3, 2021EXHIBITPETITIONER

Nee 2014

Feb 3, 2021EXHIBITPETITIONER

Byrn Declaration

Feb 3, 2021EXHIBITPETITIONER

Petition for Inter Partes Review

Feb 3, 2021PAPERPETITIONER

Petitioner Nevakar, Inc.'s Power of Attorney and Designation of Lead and Backup Counsel

Feb 3, 2021PAPERPETITIONER

Petitioner's Exhibit List

Feb 3, 2021PAPERPETITIONER